Connection
Scott Sagel to Clinical Trials as Topic
This is a "connection" page, showing publications Scott Sagel has written about Clinical Trials as Topic.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.430 |
|
|
|
-
Sagel SD. Identifying novel endpoints for cystic fibrosis clinical trials. Adv Pediatr. 2005; 52:115-27.
Score: 0.177
-
Sagel SD. The challenges of developing effective anti-inflammatory agents in cystic fibrosis. J Cyst Fibros. 2015 Mar; 14(2):164-6.
Score: 0.088
-
Rowe SM, Borowitz DS, Burns JL, Clancy JP, Donaldson SH, Retsch-Bogart G, Sagel SD, Ramsey BW. Progress in cystic fibrosis and the CF Therapeutics Development Network. Thorax. 2012 Oct; 67(10):882-90.
Score: 0.075
-
Sagel SD, Chmiel JF, Konstan MW. Sputum biomarkers of inflammation in cystic fibrosis lung disease. Proc Am Thorac Soc. 2007 Aug 01; 4(4):406-17.
Score: 0.053
-
Sagel SD, Accurso FJ. Monitoring inflammation in CF. Cytokines. Clin Rev Allergy Immunol. 2002 Aug; 23(1):41-57.
Score: 0.037